Bioethics and release of incidental genomic findings

  • Thread starter Thread starter jim mcnamara
  • Start date Start date
  • Tags Tags
    Release
Click For Summary

Discussion Overview

The discussion revolves around the ethical implications of releasing incidental genomic findings to patients, particularly in the context of genetic predispositions to diseases. It explores the policies surrounding patient consent and the potential consequences of providing such information, as well as the broader societal and ethical considerations involved.

Discussion Character

  • Debate/contested
  • Ethical discussion
  • Exploratory reasoning

Main Points Raised

  • Some participants propose that patients should be informed about incidental genomic findings, as many diseases have a genetic component, and the ethical standard should lean towards transparency.
  • Others argue that the decision to provide such information should be contingent on patient consent, with current policies primarily focusing on asking patients if they want to receive this information.
  • A participant raises concerns about the accuracy of genomic data, questioning whether false positives or negatives could lead to unnecessary anxiety for patients.
  • Another viewpoint emphasizes the right of individuals to know about their genetic predispositions, suggesting that ethical considerations should come into play only after the information is provided.
  • Some participants acknowledge that not all individuals may want to know their genetic risks, indicating a divergence in personal preferences regarding this information.

Areas of Agreement / Disagreement

Participants express differing opinions on whether incidental genomic findings should be routinely disclosed to patients. While some advocate for transparency and the right to know, others emphasize the importance of consent and the potential for causing undue worry.

Contextual Notes

The discussion highlights the complexities of ethical decision-making in the context of rapidly advancing genetic testing technologies, with no consensus on how to balance patient rights with potential psychological impacts.

jim mcnamara
Mentor
Messages
4,789
Reaction score
3,852
This post is in GD because there is no one agreed upon answer even though it deals with genetic data and its use. It is an ethics discussion...

https://science.sciencemag.org/content/373/6555/610
Incidental genomic data means giving patients extra information about what is found in a vounteer patient genome that has potential for disease ( example: like the BRCA gene and breast cancer). As it stands now the policy mostly seems to be to ask the patient if they want the information, and to give it to them only with their consent.

So you understand the magnitude of the problem, consider how many disease processes have a genetic component - literally thousands.

Many are orphan diseases that kind of oddball things, like oyster borne Vibrio (bacterium) disease which may kill someone who has both the wrong gene and has eaten raw oysters that are infected. People without the gene usually will not have a severe problem. Obviously if you don't eat oysters or always eat them cooked - no problem.

Other rare conditions like Kearns-Sayre Syndrome, a genetic defect in mitochondrial DNA, may be partially mediated if caught early and may be a more severe problem otherwise.

https://www.ninds.nih.gov/Disorders/All-Disorders/Kearns-Sayre-Syndrome-Information-Page

The point is: do we or do we not give people information like this as a de facto ethical standard of procedure?
 
Biology news on Phys.org
I saw a documentary today of a film team who accompanied several persons with trisomy for over a year. One woman fought for it shouldn't be allowed to have late abortions if prenatal testing showed trisomy and that the costs for the tests shouldn't be covered by the general health insurance.

She said "I do not want to be aborted. I want to stay in this world." What she really said is, that nobody should ever be allowed to tell her, that she wouldn't be there if the law only had been in place earlier.

Our government has an ethics commission where such topics are discussed. But as usual, the key lies in the appointments. The more we are able to do biochemically, the harder it is to achieve an ethical commitment in time. We cannot debate all topics long and publically enough.

The information about a genetic predisposition shouldn't be a question. A person must have the right to know what others know about them! Ethics can only jump in when the consequences are evaluated, not before. The only other acceptable solution is not to test.
 
jim mcnamara said:
As it stands now the policy mostly seems to be to ask the patient if they want the information, and to give it to them only with their consent.
Is this a routine question on the forms that patients fill out when enrolling in those studies? If so, I think it's covered pretty well. It might be good if there were perhaps different categories of such information, ranging from "You definitely have something that we can treat/prevent right now" to "With this gene you have a low chance of developing this condition".

And is there a chance that such data in the sequencing could be wrong, and cause false worry in the patient? I know with standard tests for certain things, there is usually a chance for false positive/negative that will prompt a second set of tests to verify before starting any treatments...
 
jim mcnamara said:
The point is: do we or do we not give people information like this as a de facto ethical standard of procedure?
I think the information should be offered. I'd want to know, and my wife already knows her situation. Both of us have relatives (parents, aunts/uncles, cousins) with certain illnesses that have some familial/genetic component. I'm aware that some don't want to know.
 

Similar threads

  • · Replies 2 ·
Replies
2
Views
5K
Replies
2
Views
3K
  • · Replies 3 ·
Replies
3
Views
6K
  • · Replies 14 ·
Replies
14
Views
17K